Status: Approved
Entry Type: Unknown
Molecule Category: Salt
Parent Compound: ANLOTINIB

Indications

Mesh Heading Maximum Phase Reference
Chordoma Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Hepatocellular; Recurrence Phase 1/Phase 2 ClinicalTrials
Sarcoma Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 3 ClinicalTrials
Breast Neoplasms Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 2 ClinicalTrials
Sarcoma Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Hepatocellular Phase 2 ClinicalTrials
Lung Neoplasms Phase 2 ClinicalTrials
Lung Neoplasms; Small Cell Lung Carcinoma Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung Phase 4 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 1 ClinicalTrials
Small Cell Lung Carcinoma Phase 2 ClinicalTrials
Lung Neoplasms; Small Cell Lung Carcinoma Phase 4 ClinicalTrials

Related Entries

Parent